SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-029335
Filing Date
2021-05-21
Accepted
2021-05-21 16:59:05
Documents
12
Period of Report
2021-05-20
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K vktx-8k_20210520.htm   iXBRL 8-K 65514
  Complete submission text file 0001564590-21-029335.txt   196412

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vktx-20210520.xsd EX-101.SCH 5816
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vktx-20210520_lab.xml EX-101.LAB 19478
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vktx-20210520_pre.xml EX-101.PRE 11660
5 EXTRACTED XBRL INSTANCE DOCUMENT vktx-8k_20210520_htm.xml XML 3562
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37355 | Film No.: 21949896
SIC: 2834 Pharmaceutical Preparations